---
title: "12 Health Care Stocks Moving In Monday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303992785.md"
description: "Healthcare stocks experienced significant volatility in Monday's intraday session. Gainers included Inovio Pharmaceuticals, which surged 211.2% to $1.88, and BeyondSpring, up 26.74%. IDEXX Laboratories also rose nearly 20%, following its Q3 earnings report. Conversely, major losers featured Karyopharm Therapeutics, which plummeted 83.5% to $0.11, and Bright Minds Biosciences, down 59.83%. Other notable declines occurred in Jaguar Health and NeuroSense Therapeutics."
datetime: "2026-11-02T17:05:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303992785.md)
  - [en](https://longbridge.com/en/news/303992785.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303992785.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's Intraday Session

### Gainers

-   **Inovio Pharmaceuticals** (NASDAQ:INO) shares rose 211.2% to $1.88 during Monday's regular session. The company's market cap stands at $62.2 million.
-   **BeyondSpring** (NASDAQ:BYSI) stock moved upwards by 26.74% to $0.82. The company's market cap stands at $26.4 million.
-   **Genenta Science** (NASDAQ:GNTA) stock rose 25.35% to $0.78. The company's market cap stands at $14.4 million.
-   **Acumen Pharmaceuticals** (NASDAQ:ABOS) shares moved upwards by 21.98% to $0.26. The company's market cap stands at $15.1 million.
-   **IDEXX Laboratories** (NASDAQ:IDXX) stock increased by 19.75% to $660.13. The market value of their outstanding shares is at $43.4 billion. As per the news, the Q3 earnings report came out today.
-   **InspireMD** (NASDAQ:NSPR) shares rose 19.39% to $0.54. The market value of their outstanding shares is at $21.0 million.

### Losers

-   **Karyopharm Therapeutics** (NASDAQ:KPTI) shares decreased by 83.5% to $0.11 during Monday's regular session. The market value of their outstanding shares is at $15.0 million.
-   **Bright Minds Biosciences** (NASDAQ:DRUG) stock fell 59.83% to $22.09. The company's market cap stands at $539.4 million.
-   **Jaguar Health** (NASDAQ:JAGX) stock declined by 49.09% to $0.82. The company's market cap stands at $3.7 million.
-   **NeuroSense Therapeutics** (NASDAQ:NRSN) shares fell 42.74% to $1.14. The market value of their outstanding shares is at $3.7 million.
-   **Nordicus Partners** (NASDAQ:NORD) shares fell 28.34% to $3.52. The company's market cap stands at $95.5 million.
-   **GlucoTrack Inc** (NASDAQ:GCTK) shares fell 27.79% to $0.58. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [ABOS.US](https://longbridge.com/en/quote/ABOS.US.md)
- [BYSI.US](https://longbridge.com/en/quote/BYSI.US.md)
- [DRUG.US](https://longbridge.com/en/quote/DRUG.US.md)
- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)
- [GNTA.US](https://longbridge.com/en/quote/GNTA.US.md)
- [IDXX.US](https://longbridge.com/en/quote/IDXX.US.md)
- [INO.US](https://longbridge.com/en/quote/INO.US.md)
- [JAGX.US](https://longbridge.com/en/quote/JAGX.US.md)
- [KPTI.US](https://longbridge.com/en/quote/KPTI.US.md)
- [NORD.US](https://longbridge.com/en/quote/NORD.US.md)
- [NRSN.US](https://longbridge.com/en/quote/NRSN.US.md)
- [NSPR.US](https://longbridge.com/en/quote/NSPR.US.md)
- [SAEN.US](https://longbridge.com/en/quote/SAEN.US.md)
- [KPTIQ.US](https://longbridge.com/en/quote/KPTIQ.US.md)

## Related News & Research

- [GlucoTrack delays third-quarter report over derivative valuations](https://longbridge.com/en/news/305810191.md)
- [JAGX: Debt fell by over $10 million as focus shifted to rare intestinal-failure milestones](https://longbridge.com/en/news/305841926.md)
- [Jaguar Health 3Q 2026: Revenue $2.34M, EPS ($9.23) — 10-Q Summary](https://longbridge.com/en/news/305664375.md)
- [InspireMD (NSPR) Q3 2026 Earnings Call Transcript](https://longbridge.com/en/news/305429741.md)
- [BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update | BYSI Stock News](https://longbridge.com/en/news/305512176.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**